Cagent Vascular announced the publication of data demonstrating the safety and efficacy of the company’s Serranator percuta ...

Reva Medical, LLC announced primary endpoint results from the pivotal MOTIV BTK randomized clinical trial evaluating the safety a ...

A new study suggests that a novel anti-clotting drug may reduce the risk of a second stroke without increasing bleeding, ...

Although there was a low incidence of ischemic vascular complications, those who had them showed higher rates of all-cause ...

Love a little heat? A 2025 study in the Chinese Medical Journal found weekly spicy food consumption was linked to a lower ...

New data from the PROMISE III trial show the LimFlow transcatheter deep venous arterialization system achieved over 80% amputation-free survival at six months in 'no-option' chronic limb-threatening ...

Transcatheter deep venous arterialization was tied to high rates of limb salvage and wound healing in patients with “no ...

Syphilis is independently linked to an elevated risk for major cardiovascular events and death, with the strongest ...

Severe stroke survivors face 5x higher dementia risk, while even minor strokes double the odds of cognitive decline.

Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment ...

Infection with syphilis is associated with an increased risk for several major adverse cardiovascular outcomes and death, according to a study published online ...

Data from the PROMISE III trial suggest that chronic limb-threatening ischemia (CLTI) patients with no other treatment ...